Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03142334
Brief Title: Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

First Submitted : May 3, 2017
First Submitted that Met QC Criteria : May 3, 2017
First Posted : May 5, 2017

Last Update Submitted that Met QC Criteria : September 23, 2019
Last Update Posted : September 25, 2019